Locations:
Search IconSearch
October 14, 2020/Neurosciences

Treating Sleep Disturbances in Young Children With Autism

Parent training intervention leads to significant improvement in sleep problems

Sleeping child

Up to 80% of children with autism spectrum disorder (ASD) also have at least moderate sleep disturbances. Disordered sleep in children with autism can amplify already delayed social interactions, repetitive behaviors, affective problems, inattention/hyperactivity and irritability.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In a prior NIH-funded study (R34MH082882), the principal investigator, Cynthia R. Johnson, PhD, Director of the Cleveland Clinic Children’s Center for Autism, showed that a five-session, individually delivered parent training intervention for young children with ASD and sleep disturbances resulted in significant improvements in sleep problems compared with the control group, which received five sessions of an education program relevant to young children with ASD.1

This study was delivered in a tertiary, specialized setting requiring parents to make many trips to an urban area; some families traveled over two hours to participate. Now, with funding from the Department of Defense, Dr. Johnson and her team will further test this manualized parent training program specifically targeting bedtime and sleep disturbance but delivered via a telehealth platform. This four-year randomized control trial is actively recruiting (email autismresearch@ccf.org for more information). If we demonstrate that this manualized parent training program specifically targeting sleep disturbances can be delivered with fidelity and efficacy via a telehealth platform, this has broad implications for clinical service delivery to reach children and families living at a distance from a specialized autism center.

References

  1. Johnson CR, Turner KS, Foldes E, et al. Behavioral parent training to address sleep disturbances in young children with autism spectrum disorder: a pilot trial. Sleep Med. 2013 Oct; 14(10):995-1004.

Advertisement

Related Articles

Two people working in a community garden
Rehabilitation: Beyond Recovery, Toward Renewed Participation

Tasked-based therapy improves social connection and quality of life

gloved hand holding blood vial with neuropathology slide in background
October 10, 2025/Neurosciences/Epilepsy
Blood-Based Epigenetic Biomarkers Differentiate Focal Cortical Dysplasia Subtypes

Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis

young man using walking canes on a city street
Vidofludimus for Progressive MS: No Impact on Brain Atrophy but Hints of a Role for Disability

Mixed results from phase 2 CALLIPER trial of novel dual-action compound

illustration of myelin sheaths wrapped around neuron axons
Revised McDonald Criteria for Multiple Sclerosis: A Big Step Toward Biomarker-Driven Diagnosis

A co-author of the new recommendations shares the updates you need to know

Dr. Jason Savage against a decorative background with podcast button overlay
October 2, 2025/Neurosciences/Podcast
Essentials of Revision Spine Deformity Surgery (Podcast)

Success for these complex operations requires judicious patient selection and presurgical patient optimization

physician talking with a patient in medical office
De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at Outcomes

Rebound risk is shaped by patient characteristics and mechanism of action of current DMT

woman speaking to a doctor
Tool Shows Promise for Individualized Decision Support on Stopping Disease-Modifying Therapy for Multiple Sclerosis

First-of-kind prediction model demonstrates high consistency across internal and external validation

health worker preparing infusion of injectable drug
Ocrelizumab Associated With Nearly Twofold Increase in Serious Infections Vs. Platform Injectables in Multiple Sclerosis

Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age

Ad